Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The collaboration between the chipmaker and Abridge, a developer of generative AI for healthcare, will involve data-sharing to improve Nvidia’s general-purpose models, which in turn will be used to make Abridge’s clinical offerings more efficient.
The Kentucky-based insurance giant had owned a 40% stake in the hospice company, stemming from its 2021 acquisition of Kindred Healthcare. Humana said a “consortium of investors" is making the buy, but few details were revealed.
The buyout, announced last summer, drew the attention of federal regulators at the Federal Trade Commission, concerned that competition for ambulatory surgery services would be stifled by the merger. To appease the agency, Ascension has agreed to divest from some centers previously owned by Amsurg.
When Mayo Clinic and Microsoft announced last week that they’re partnering to develop a frontier AI model for healthcare, observers could see where Mayo’s expertise in advanced digital medicine would interest Microsoft. The Big Tech behemoth has not been coy about its healthcare ambitions.
Acotec, founded in 2008, designs and distributes a wide range of medical devices used in interventional cardiology, including drug-coated balloons and thrombus aspiration catheters.
An AI startup has been cleared to market a platform for precisely mapping prostate cancer with 3D visualization so the tumor can be treated without harm to healthy surrounding prostate tissue.
More than half of surveyed radiologists worry about MRI contrast availability, yet almost all—99%—wish for contrast agents that would cut current gadolinium concentrations at least in half.
Last fall Yale Radiology began offering users of its EHR-based patient portal a link to a page on RadiologyInfo.org headed “How to read your radiology report.” The page drew 400 or so clicks in its first two weeks. Today it’s getting 5,000 to 10,000 a month.
Aidence will license, develop, and validate Google Health’s existing AI research module, hoping to offer better differentiation between benign and malignant lung nodules at an early stage.